ENDOSTAR

作品数：33被引量：127H指数：6
导出分析报告
相关领域：医药卫生更多>>
相关作者：戈伟李长虎俞志英尹预真周菊英更多>>
相关机构：武汉大学苏州大学中国药科大学第二军医大学更多>>
相关期刊：《Oncology and Translational Medicine》《四川医学》《中文科技期刊数据库（文摘版）医药卫生》《外文科技期刊数据库（文摘版）医药卫生》更多>>
相关基金：国家自然科学基金湖北省卫生厅科研基金湖北省自然科学基金桂林市科学研究与技术开发项目更多>>
-
在结果中检索

检索结果分析

结果分析中...
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Effect of Endostar combined with concurrent chemoradiotherapy in patients with locally advanced cervical cancer
《Radiation Medicine and Protection》2023年第2期104-108,共5页Hengzhao Zhuang Yang Jiao Xin Li Jingping Yu Juying Zhou Lili Wang 
supported by the National Natural Science Foundation of China(82073476 and 81773226);the National Key R&D Program of China(2022YFC2503700,2022YFC2503703);Innovation Research Project of Medical and Industrial Cooperation in Suzhou(SLJ2021005);the Priority Academic Program Development(PAPD)of Jiangsu Higher Education Institutions,China.
ObjectiveTo explore the value of Endostar in the clinical application of locally advanced cervical cancer.MethodsA total of 107 patients with locally advanced cervical cancer who received concurrent chemoradiotherapy(...
关键词：Cervical cancer Recombinant human Endostatin Concurrent chemoradiotherapy Propensity score matching 
Meta-analysis of efficacy and safety of Endostar combined with vinorelbine and cisplatin in the treatment of non-small cell lung cancer
《Journal of Hainan Medical University》2022年第8期29-35,共7页Ze-Yun Li Qing-Xia Lan Cheng-Xin Liu Zhe Sun Yang Cao 
General Program of the National Natural Science Foundation of China(No.81973815);General Program of Fund of the Traditional Chinese Medicine Bureau of Guangdong Province(No.20201107)。
Objective:To systematically evaluate the efficacy and safety of rh-endostain(YH-16,Endostar)combined with vinorelbine and cisplatin(NP regimen)in the treatment of non-small cell lung cancer(NSCLC),and to provide evide...
关键词：Rh-endostain VINORELBINE CISPLATIN Non-small cell lung cancer Therapeutic efficacy Safety META-ANALYSIS 
Clinical Observation of Recombinant Human Vascular Endostatin-targeted Therapy Combined with Chemotherapy for a Variety of Malignant Tumors
《外文科技期刊数据库(文摘版)医药卫生》2022年第2期055-058,共4页LUOXi 
Objective: malignant tumor is recognized as one of the most terrible and difficult diseases to treat in the world medical system. At present, the common methods to treat malignant tumors are radiotherapy, chemotherapy...
关键词：malignant tumor CHEMOTHERAPY recombinant human vascular endostatin (rh-Endostatin ENDOSTAR grace degree) targeted therapy clinical treatment effect 
Study on the Clinical Efficacy and Safety of Endostar Combined with Pemetrexed and Cisplatin in the Treatment of Lung Adenocarcinoma
《Proceedings of Anticancer Research》2020年第6期16-19,共4页Yanbing Wang 
Objective:To analyze and study the efficacy and safety of Endu combined with pemetrexed and cisplatin in the clinical treatment of lung adenocarcinoma.Methods:From August 2016 to September 2020,32 patients with lung a...
关键词：ENDOSTAR PEMETREXED CISPLATIN Lung adenocarcinoma Clinical efficact Safety 
Effect of Endostar combined with Paclitaxel on the proliferation and migration of metalloproteinases and tumor cells in NSCLC patients被引量：1
《Journal of Hainan Medical University》2019年第19期48-52,共5页Qi Yong-Jian Zeng Xue-Hua Lai Ju-Ju Zha Wang-Jian 
Science and Technology Project of Jiangsu Provincial Hospital of Traditional Chinese Medicine (Y14066)
Objective: To explore the effect of endostar combined with taxol on tumor markers, vascular endothelial growth factor, neuron-specific enolase, metalloproteinase and tumor cell proliferation and migration in NSCLC pat...
关键词：ENDOSTAR PACLITAXEL NSCLC Metalloproteinase Proliferation and migration 
Comparison of intra-pleural injection efficacy between Endostar and Bevacizumab combined with pemetrexed/cisplatin for the treatment of malignant pleural effusion in patients with epidermal growth factor receptor-/anaplastic lymphoma kinase-lung adenocarci被引量：1
《Oncology and Translational Medicine》2019年第2期53-57,共5页Yi Cheng Nan Huang Kai Qin Jing Zhao Huihua Xiong Shiying Yu Tingting Huang Qiuyun Guo 
Supported by a grant from the Nature Science Foundation of Hubei Province,China(No.2017CFB472)
Objective To compare intra-pleural injection efficacy and safety between Endostar and bevacizumab combined with pemetrexed/cisplatin for the treatment of malignant pleural effusion in patients with epidermal growth fa...
关键词：ENDOSTAR BEVACIZUMAB malignant PLEURAL effusion EGFR-/ALK-lung adenocarcinoma CISPLATIN PEMETREXED intra-pleural injection 
持续泵入endostar(恩度)同步TMZ(替莫唑胺)化疗治疗进展期恶性黑色素瘤的疗效观察
《中文科技期刊数据库（文摘版）医药卫生》2019年第4期69-70,共2页张洪强 张怡 王炳 王洪波 曲兴龙 
上海市闵行区科委科研课题(No2017MHJ69)
观察持续泵入恩度同步替莫唑胺化疗治疗进展期恶性黑色素瘤患者的临床疗效。方法:选取60例2015年12月至2017年12月在我院治疗的进展期恶性黑色素瘤患者,将其随机分为对照组和观察组,各30例,给对照组患者单纯给予替莫唑胺治疗,给观察组...
关键词：持续泵入 恩度 替莫唑胺 进展期恶性黑色素瘤 
重组人血管内皮抑制素对大鼠脉络膜新生血管的影响被引量：2
《中国老年学杂志》2018年第20期5038-5040,共3页李伟 苏锐锋 付笑笑 杨洁 张垒 谭小波 苏畅 
河北省自然科学基金面上项目(H2015406054)
目的探讨重组人血管内皮抑制素Endostar对大鼠脉络膜新生血管的影响。方法将24只大鼠随机分为对照组、模型组(脉络膜新生血管组)和Endostar组(脉络膜新生血管+Endostar组),每组8只。模型组和Endostar组大鼠建立脉络膜新生血管模型;脉络...
关键词：ENDOSTAR 脉络膜新生血管 血管内皮细胞生长因子 CXC趋化因子配体1 低氧诱导因子-1Α 
Safety and efficacy of multi-kinase inhibitor plus endostar treatment in patients with metastatic renal cell carcinoma and pleural effusion
《Oncology and Translational Medicine》2018年第1期10-12,共3页Wei Luan Wenxin Li 
Objective The aim of this study was to evaluate the safety and efficacy of multi-kinase inhibitor plus endostar treatment in patients with metastatic renal cell carcinoma(m RCC) and pleural effusion. Methods A total o...
关键词：RENAL cell carcinoma PLEURAL EFFUSION multi-kinase INHIBITOR ENDOSTAR 
Effect of intensity modulated radiation therapy combined with paclitaxel+ endostar chemotherapy on serum malignant molecule levels in patients with locally advanced non-small cell lung cancer被引量：1
《Journal of Hainan Medical University》2017年第20期109-113,共5页Hong-Wei Zhang 
Objective: To discuss the effect of intensity modulated radiation therapy combined with paclitaxel + endostar chemotherapy on serum malignant molecule levels in patients with locally advanced non-small cell lung cance...
关键词：NON-SMALL cell lung cancer Intensity modulated radiation therapy CHEMOTHERAPY Tumor marker ANGIOGENESIS index 
全选清除导出
共4页<1234>
检索报告 对象比较 聚类工具 使用帮助 返回顶部